Compares paired and unpaired GAN models with diffusion and transformer methods for MRI synthesis, highlighting efficiency and fidelity in clinical usage.
Incomplete or faulty MRI sequences are common in clinical practice and can impair AI-based analyses that rely on complete multi-contrast data. The relative effectiveness of classical generative adversarial networks (GANs) versus modern diffusion and transformer-based models for clinically usable MRI synthesis remains unclear. This study evaluates cross-modality MRI synthesis using the BraTS 2019 brain tumour dataset, focusing on T1-to-T2 translation. We assess paired and unpaired CycleGAN models and compare them with two stronger but computationally intensive baselines, a conditional denoising diffusion probabilistic model (DDPM) and a transformer-enhanced GAN, using identical data splits and preprocessing pipelines. Inter-modality correlation was evaluated to estimate the achievable similarity between modalities. Conceptually, modality synthesis may be viewed as a representation-learning approach that compensates for missing imaging information by reconstructing clinically relevant features from available contrasts. Paired CycleGAN achieved correlations of r≈0.92–0.93 and SSIM ≈0.90–0.92, approaching natural T1–T2 correlation (r≈0.95) while maintaining very fast inference (<50 ms/slice). Unpaired CycleGAN achieved r≈0.74–0.78 and SSIM ≈0.82–0.85, producing clinically interpretable reconstructions without voxel-level supervision. DDPM achieved the highest fidelity (SSIM ≈0.93–0.95, r≈0.94) but required substantially greater computational resources, while transformer-enhanced GAN performance was intermediate. Qualitative analysis showed that CycleGAN and DDPM best preserved tumour and tissue boundaries, whereas unpaired CycleGAN occasionally over-smoothed subtle lesions. These findings highlight the trade-off between fidelity and efficiency in cross-modality MRI synthesis, suggesting paired CycleGAN for time-sensitive clinical workflows and diffusion models as a computationally expensive accuracy upper bound.
No takes yet. Share an insight, caveat, or question.
Kalejahi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: